Johanna Bendell, MD
SCRI Development Innovations, LLC · Sarah Cannon Research Instititue (SCRI) · Duke Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Johanna Bendell, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:36 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT03775850 · A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed TumorsEvelo Biosciences, Inc. · completed · Colorectal Cancer Metastatic, Triple Negative Breast Cancer, Non Small Cell Lung Cancer · principal investigator
- Ph1NCT02740985 · A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid MalignanciesAstraZeneca · completed · Advanced Solid Malignancies, Non-Small Cell Lung Cancer (NSCLC), Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC) · study chair
- Ph1NCT02574663 · TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid TumorsTG Therapeutics, Inc. · completed · Pancreatic Cancer, Colorectal Cancer, Rectal Cancer · study chair
- Ph2NCT02195011 · Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver MetastasesSCRI Development Innovations, LLC · completed · Colorectal Neoplasms · study chair
- Ph1NCT01867879 · Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid TumorsTaiho Oncology, Inc. · completed · Advanced Solid Tumors (Excluding Breast Cancer) · principal investigator
- Ph2NCT01404650 · Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal TumorSCRI Development Innovations, LLC · completed · Gastrointestinal Stromal Tumor · study chair
- Ph2NCT01226719 · FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases OnlySCRI Development Innovations, LLC · completed · Colorectal Cancer · study chair
- Ph1NCT01154335 · Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal CancerSCRI Development Innovations, LLC · completed · Metastatic Colorectal Cancer · study chair
- Ph3NCT01097018 · Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal CancerAEterna Zentaris · completed · Colorectal Cancer · principal investigator
- Ph1NCT01048580 · Study of Perifosine + Capecitabine for Colon Cancer PatientsAEterna Zentaris · completed · Colon Cancer · study chair
- Ph2NCT00613080 · Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal CancerRadiation Therapy Oncology Group · completed · Colorectal Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in colorectal cancer.